Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
TLSI Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
45%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
17.90%
TLSI Stock Analysis
TLSI
PE Ratio:
TLSI
PEG Ratio:
Not Available
TLSI
Forward EPS Growth (12 month):
0.00%
TLSI
PS Ratio:
2.7
TLSI
PSG Ratio:
0.1
TLSI
Forward Revenue Growth (12 month):
49.20%
TLSI Articles
No data was found